K
Kopran Ltd
Pharmaceuticals
SMALLCAP
Pharmaceuticals
Live Performance vs
This is a tool to communicate factual return information and should not be seen as an advertisement or promotion
| Key Metrics | This Stock | Category (Avg) |
| PE Ratio | 16.85 | 37.31 |
| PB Ratio | 1.25 | 5.90 |
| Dividend Yield | 2.23% | 0.58% |
Understand what these metrics mean.
Peer Stocks
For peer comparison & financials,
About the company
K
Kopran Ltd
Kopran Limited is engaged in pharmaceutical business. The Company's business units include Finished Dosage Forms, Active Pharmaceutical Ingredients, Research and Development, and Consumer Healthcare.
Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions